BOSTON – Crowding in prisons dramatically increases the risk for COVID-19 infections among inmates, according to a new study by researchers at Massachusetts General Hospital (MGH). The authors of the study, published in JAMA Internal Medicine, argue that policy changes are necessary to protect the vulnerable population of incarcerated men and women.
Earlier studies found that the incidence of COVID-19 infection is significantly higher in prisons than in the general population, but the degree to which crowding contributed to the problem was unknown. The senior author of the JAMA Internal Medicine study, MGH infectious diseases physician Amir Mohareb, MD, has worked on a pro bono basis with several advocacy groups working to ensure that infection control measures are implemented in prisons during the coronavirus pandemic. One group he advised, Prisoners’ Legal Services of Massachusetts, was suing the state’s Department of Correction over its practices. Mohareb and his colleagues analyzed a trove of data in Massachusetts that allowed them to examine more closely what’s driving the high incidence of COVID-19 in prisons.
One element the data lacked was detailed information about each individual inmate who became ill, which would have allowed Mohareb and his team to study the characteristics of who got COVID-19 and who didn’t. However, they had other critical data, including weekly reports on the number of positive COVID-19 tests at 14 Massachusetts state prisons, the population of each prison, and the number of inmates the facility was designed to hold (known as design capacity). “So we asked, What are characteristics of these facilities that might lead to more COVID-19 transmission?” says Mohareb, who is also a researcher at MGH’s Medical Practice Evaluation Center.
Their analysis found that crowding at the facilities varied greatly during the observation period, with the population at some dropping as low as 25 percent of design capacity, while others were extremely crowded, reaching up to 155 percent of design capacity. Mohareb and his colleagues found that as facilities became more crowded, the threat to inmates rose: Every increase of 10 percentage points in a prison population relative to the facility’s design capacity raised the risk of getting infected with COVID-19 by 14 percent. As Mohareb notes, that means a facility doesn’t have to be exceeding its design capacity to increase the danger for inmates, since a prison that’s operating at 80 percent capacity is riskier than one at 70 percent capacity. “We may need to have stricter thresholds for where we draw the line on how crowded a facility can be,” he says.
To study the effect of crowding another way, Mohareb’s team calculated the percentage of inmates in each prison who were housed in single cells during each week of the observation period. They found that every 10-percentage-point increase in the proportion of inmates living in single cells reduced the risk of COVID-19 infection in that prison by 18 percent.
Similar to other studies, this investigation found that inmates in prisons have a significantly greater risk—more than sixfold—for becoming infected with COVID-19 compared to the general public. But in a novel finding, Mohareb and colleagues showed that infection rates in prisons tended to reflect those of their surrounding communities. “We found a very close association,” says Mohareb. When numbers of COVID-19 cases were low in Massachusetts during the summer of 2020, they tended to be low in prisons, too. And as numbers spiked in many communities late last year, they also soared in local prisons. “Prisons are intricately linked to their surrounding communities,” says Mohareb, noting that greater attention to infection control (through vaccination and routine testing) among guards, support staff, vendors, and others who come and go from these facilities is essential.
While COVID-19 vaccination became available to inmates in Massachusetts state prisons earlier this year, it is optional; what’s more, news reports indicate that a significant portion of prison workers remain unvaccinated. Mohareb and his coauthors argue that policymakers should strongly consider decarceration—releasing prisoners deemed to be at low risk for reoffending—as a way to lower the risk for COVID-19 in prisons. “It was the almost universal opinion of experts in public health, infectious disease and epidemiology from the start of the pandemic that prisons were going to be places of immense suffering unless inmates were released in a coordinated manner,” says Mohareb. “And that really didn’t happen.”
Mohareb is also an instructor in Medicine at Harvard Medical School (HMS). Abigail I. Leibowitz, the first author of the paper, completed this work while earning a master’s degree in public health at the Harvard T.H. Chan School of Public Health and is currently a medical student at the University of Colorado. Other authors include MGH infectious disease physician Mark Siedner, MD, MPH, an associate professor of Medicine at HMS, and MGH psychiatrist Alexander C. Tsai, MD, PhD, an associate professor of Psychiatry at HMS.
Support for this work was provided by the National Institutes of Health and the Sullivan Family Foundation.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2021, Mass General was named #5 in the U.S. News & World Report list of "America’s Best Hospitals."
JAMA Internal Medicine
Method of Research
Subject of Research
Association Between Prison Crowding and COVID-19 Incidence Rates in Massachusetts Prisons, April 2020-January 2021
Article Publication Date
Ms Leibowitz reported provision of pro bono advising in support of Prisoners’ Legal Services of Massachusetts in litigation against the Massachusetts Department of Correction regarding the agency’s response to COVID-19. Dr Tsai reported receiving grants from the Sullivan Family Foundation during the conduct of the study; other from Public Library of Science (stipend for work as specialty consulting editor for PLOS Medicine) and other from Elsevier (stipend for work as editor in chief of SSM Mental Health) outside the submitted work. Dr Mohareb reported receiving grants from the National Institutes of Health (T32AI007433) outside the submitted work; and provision of pro bono advising and written expert declarations in the following litigation regarding COVID-19 and incarcerated persons: Mays v Dart (Ill 2020), Foster v Mici (Mass 2020, 2021), and Savino v Hodgson (Mass 2020). No other disclosures were reported.